IMO nan should use their SP for some acquisitions either script take over or CR. They need to expand their distribution network in asian and europe. Rather than replication takeover a synergistic medical distribution company. You get efficiencies of scale and an instant network and potential goodwill with the right purchase. Alternatively takeover of a related disinfection company to increase portfolio and reduce risk.
Is NAN the BEST Growth Story on the ASX MF, page-3
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.75 |
Change
-0.020(0.72%) |
Mkt cap ! $833.2M | |||
| Open | High | Low | Value | Volume |
| $2.79 | $2.80 | $2.74 | $2.322M | 840.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7145 | $2.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.75 | 48317 | 6 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| NAN (ASX) Chart |